Guus P Leijte Selected Research

Guus P Leijte Research Topics

6	Sepsis (Septicemia) 01/2020 - 01/2019
5	Endotoxemia 01/2021 - 01/2019
3	Inflammation (Inflammations) 01/2021 - 01/2019
2	Infections 01/2020 - 01/2018
1	Critical Illness (Critically Ill) 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Wounds and Injuries (Trauma) 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017
1	Leukemia 01/2017

5	EndotoxinsIBA 01/2021 - 01/2019
3	CytokinesIBA 01/2020 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	Iohexol (Omnipaque)FDA Link 01/2020 - 01/2020
2	LipopolysaccharidesIBA 01/2020 - 04/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2019
2	HLA-DR Antigens (HLA-DR)IBA 01/2020 - 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	CreatinineIBA 01/2020
1	proenkephalinIBA 01/2020
1	InterleukinsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Chemotactic FactorsIBA 01/2020
1	Cell Adhesion MoleculesIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	HMGB1 Protein (HMG1)IBA 01/2018

1	Intravenous Administration 01/2021
1	Precision Medicine 01/2019
1	Therapeutics 01/2019
1	Cytoreduction Surgical Procedures 01/2018
1	Hyperthermic Intraperitoneal Chemotherapy 01/2018
1	Operative Surgical Procedures 01/2018
1	Drug Therapy (Chemotherapy) 01/2017